Psychedelics – News and Features

Researchers at Columbia University have discovered that a small group of neurons fired haphazardly in mice with signs of schizophrenia.

Hair testing with LCMS shows high prevalence of new psychoactive substance use among NYC nightclub and festival attendees

Results of the study could affect the treatment of mental illnesses such as depression or anxiety.

Baebies Inc. receives FDA approval for it benchtop screening device for lysosomal storage disease. The device quantitatively measures the activity of lysosomal enzymes from newborn dried blood spots.

Bryan Roth's lab at UNC-Chapel Hill have solved the structure of the LSD-bound serotonin receptor. The work took several years to produce but could open up therapeutic approaches in the treatment of stress and headaches.

When combined with psychological counseling, a single dose of a mind-altering compound contained in psychedelic mushrooms significantly lessens mental anguish in distressed cancer patients for months at a time, according to results of a clinical trial led by researchers at NYU Langone Medical Center.

Study extends popular 'balanced network theory'.

NCI accepts recommendations for approaches likely to make progress against cancer under the Cancer Moonshot

The consumption of LSD, short for lysergic acid diethylamide, can produce altered states of consciousness. This can lead to a loss of boundaries between the self and the environment, as might occur in certain psychiatric illnesses.

Improved accuracy could allow researchers to measure brain temperature in times of trauma when small deviations in temperature can lead to additional brain injury.